Peptide-based nucleic acid mimics(PENAMS)
AssigneeThe Regents of the University of California
InventorsVibhakar J. Shah, George L. Kenyon, Irwin D. Kuntz
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsVibhakar J. Shah, George L. Kenyon, Irwin D. Kuntz
Estimating the term…
The present invention provides novel nucleic acid mimics (termed "PENAMs") comprising a peptidic backbone and nucleotidic sidechains; the sidechains being oriented in such a way that the PENAM is homomorphous to target nucleic acids with which it can effectively hydrogen bond. Homomorphism is achieved by the incorporation of unusual sterochemical centers, including D-chiral centers and quasi-chiral centers, into the peptidic backbone. The PENAMs are useful for targeting nucleic acid sequences in order to modulate their activity in an "antisense" manner. Targeting can also be used to detect, isolate or modify target nucleic acids.
A composition useful in targeting a nucleic acid comprising a stereochemically-selected population of peptide-based nucleic acid mimics (PENAMs) each member of which comprises a sequence of at least about 4 NuAA monomers,
A free NuAA monomer that is a precursor of a NuAA monomeric subunit comprising a D-chiral center wherein said NuAA monomeric subunit comprising a D-chiral center is of the following formula:
Dependencies are inferred from the claim text.